Who do we miss when screening for postpartum depression? A population-based study in a Swedish region.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
15 05 2021
Historique:
received: 13 11 2020
revised: 04 03 2021
accepted: 08 03 2021
pubmed: 3 4 2021
medline: 22 5 2021
entrez: 2 4 2021
Statut: ppublish

Résumé

Universal screening for postpartum depression is crucial for early detection, interventions and support. The aim of this study was to describe the proportion of, and explore risk factors for, women not being offered screening, as well as for declining an offer or not being screened due to any other unknown reason. Socioeconomic, obstetrical and neonatal data, extracted from the Swedish Pregnancy Registry, for 9,959 pregnancies recorded for the Östergötland county between 2016 and 2018 were linked to Edinburgh Postnatal Depression Scale (EPDS) screening results at 6-8 weeks postpartum, extracted from medical records. Risk factors were assessed using logistic regression models and with a nomogram for easy visualization. In total, there were no recorded offers of EPDS screening in the medical records for 30.0% of women at the postpartum follow-up. Women born outside of Sweden and women reporting poor self-rated health were at increased risk of not being offered screening for postpartum depression. There is a possibility that women were offered screening or were screened, but this was incorrectly or never recorded in medical records. The majority of women were offered screening for postpartum depression, but there is room for improvement in order to achieve universal screening. Awareness among healthcare providers of the risk factors for not screening might increase adherence to guidelines for universal screening. Overcoming barriers for screening and raising the topic of mental-health issues for postpartum women should be prioritized.

Sections du résumé

BACKGROUND
Universal screening for postpartum depression is crucial for early detection, interventions and support. The aim of this study was to describe the proportion of, and explore risk factors for, women not being offered screening, as well as for declining an offer or not being screened due to any other unknown reason.
METHODS
Socioeconomic, obstetrical and neonatal data, extracted from the Swedish Pregnancy Registry, for 9,959 pregnancies recorded for the Östergötland county between 2016 and 2018 were linked to Edinburgh Postnatal Depression Scale (EPDS) screening results at 6-8 weeks postpartum, extracted from medical records. Risk factors were assessed using logistic regression models and with a nomogram for easy visualization.
RESULTS
In total, there were no recorded offers of EPDS screening in the medical records for 30.0% of women at the postpartum follow-up. Women born outside of Sweden and women reporting poor self-rated health were at increased risk of not being offered screening for postpartum depression.
LIMITATIONS
There is a possibility that women were offered screening or were screened, but this was incorrectly or never recorded in medical records.
CONCLUSIONS
The majority of women were offered screening for postpartum depression, but there is room for improvement in order to achieve universal screening. Awareness among healthcare providers of the risk factors for not screening might increase adherence to guidelines for universal screening. Overcoming barriers for screening and raising the topic of mental-health issues for postpartum women should be prioritized.

Identifiants

pubmed: 33799034
pii: S0165-0327(21)00238-X
doi: 10.1016/j.jad.2021.03.013
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-173

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Emma Bränn (E)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden. Electronic address: emma.brann@kbh.uu.se.

Emma Fransson (E)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Anna Wikman (A)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Natasa Kollia (N)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden; Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Athens, Greece.

Diem Nguyen (D)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Caroline Lilliecreutz (C)

Department of Obstetrics and Gynaecology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Alkistis Skalkidou (A)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH